Molecular Templates

Molecular Templates Inc. (MTI) is a biopharmaceutical company with a novel protein platform for developing new anti-cancer therapeutic drugs. The company has a lead compound for melanoma, which is expected to enter clinical trials within the next two years, and is developing other compounds targeting a variety of other cancers.